85-1544-97　Irgasan (5-Chloro-2-(2,4-dichlorophenoxy)phenol, Triclosan, Trichlorosan) 100g　CAS No:3380-34-5　I8610-75

特徴

• Irgasan, diphenyl ether derivative, is used as a component of cefsulodin-irgasan-novobiocin selection medium for Yersinia, a human pathogen that may contaminate animal-source food products. Because of its low antigenicity, irgasan is also a component of many antibacterial consumer products. Irgasan is a broad spectrum antimicrobial agent. It is an inhibitor of the enoyl-ACP (acyl-carrier protein) reductase component of type II fatty acid synthase (FAS-II) in bacteria and Plasmodium. It also inhibits mammalian fatty acid synthase (FASN), and may have anticarcinogenic activity.
• Synonyms:5-Chloro-2-(2,4-dichloro-3,5,6-d3-phenoxy)phenol; 2,4,4'-Trichloro-2'-hydroxydiphenyl ether
• Molecular Formula:C12H7Cl3O2
• Molecular Weight:289.54
• Appearance:Supplied as a colorless to white powder.
• Purity (HPLC):≥97%
• Infrared Spectrum:Conforms to Structure
• Identification A, B:To pass test
• Melting Point:56-58°C
• 4-Mono chlorophenols:≤0.5ug
• 2,4-dichlorophenol:≤0.1ug
• 2,8-dichlorodibenzofuran:≤0.25ppm
• 2,4,8-trichlorodibenzofuran:≤0.5ppm
• 1,3,7-trichlorodibenzo-p-dioxin:≤0.25ppm
• 2,8-dichlorodibenzo-p-dioxin:≤0.5ppm
• 2,3,7,8-tetrachlorodibenzo-p-dioxin:≤0.001ug/kg
• 2,3,7,8-tetrachlorodibenzofuran:≤0.001ug/kg
• Related Substances:Individual Impurity: ≤0.1%Total Impurities: ≤0.5%
• Water (KF):≤0.1%
• Solubility:Clear solution (1.4g in10 ml acetone
• Storage:RT
• Meets or exceeds USP specifications